Davide Rossi MD

Institute of Oncology Research, Bellinzona, Switzerland

Prof. Davide Rossi obtained the specialization in Internal Medicine and the PhD in Clinical and Experimental Medicine at the University of Eastern Piedmont, where he served as Professor of Hematology until 2015. In 2015 Prof. Rossi moved to Switzerland, where he is head of the Experimental Hematology research program at the IOR, Deputy Head of the Division of Hematology and co-chair of the Clinical Lymphoid Tumors Investigation Program at the Oncology Institute of Southern Switzerland (IOSI). Prof. Rossi’s research focuses on lymphomas and chronic lymphocytic leukemia, with more than 330 publications in international peer-reviewed journals. He is also the principal investigator of national and international clinical trials in the field of chronic lymphocytic leukemia. Prof. Rossi contributed to the development of chronic lymphocytic leukemia guidelines and co-authored the 2016 WHO Classification of Hematologic Malignancies. He serves as Editorial Board Member of Blood (the official Journal of the American Society of Hematology), Blood Cancer Discovery, and HaemaSphere (the official Journal of the European Hematology Association). Prof. Rossi is member of the Organizing Committees of the International Conference on Malignant Lymphoma (ICML) and of the Congress of the European Hematology Association (EHA). Prof. Rossi’s research is funded by grants from the European Research Council, Swiss National Fund, Oncosuisse, Leukemia and Lymphoma Society, Fond’Action and Dr. Ettore Balli Foundation.